Compare RCEL & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCEL | JYNT |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | 226 | N/A |
| Industry | Medical/Dental Instruments | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.3M | 117.3M |
| IPO Year | N/A | 2014 |
| Metric | RCEL | JYNT |
|---|---|---|
| Price | $4.36 | $8.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.88 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 259.3K | 74.8K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 133.93 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $117,696,356.00 |
| Revenue This Year | $17.17 | $12.23 |
| Revenue Next Year | $49.82 | N/A |
| P/E Ratio | ★ N/A | $91.89 |
| Revenue Growth | N/A | ★ 15.49 |
| 52 Week Low | $3.22 | $7.50 |
| 52 Week High | $7.12 | $12.88 |
| Indicator | RCEL | JYNT |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | 38.19 |
| Support Level | $4.00 | $8.00 |
| Resistance Level | $4.57 | $8.85 |
| Average True Range (ATR) | 0.39 | 0.42 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 26.95 | 4.16 |
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.